|
Male
|
0.63 (0.45–0.87)
|
0.005
|
|
Age (per year)
|
1.06 (1.06–1.09)
|
<0.001
|
|
Race (Caucasian)
|
1.40 (0.78-2.53)
|
0.26
|
|
Body Mass Index (kg/m2) (31+)
| | |
|
18–25
|
1.35 (0.90–2.03)
|
0.14
|
|
26–30
|
1.11 (0.75–1.64)
|
0.60
|
|
Ejection fraction (%)
|
1.01 (0.99–1.02)
|
0.46
|
|
Hypertension
|
1.31 (0.89–1.93)
|
0.17
|
|
Smoking
|
0.89 (0.65–1.23)
|
0.48
|
|
Chronic pulmonary disease
|
2.02 (1.37–2.96)
|
<0.001
|
|
Prior myocardial infarction
|
1.00 (0.73–1.37)
|
0.99
|
|
Prior coronary angioplasty
|
1.16 (0.81–1.65)
|
0.41
|
|
Prior coronary artery bypass graft
|
0.67 (0.21–2.09)
|
0.48
|
|
Congestive heart failure
|
1.64 (1.11–2.43)
|
0.01
|
|
Prior cerebrovascular event
|
1.79 (1.22–2.62)
|
0.003
|
|
Family history of coronary artery disease
|
0.56 (0.39–0.80)
|
0.001
|
|
Renal Failure on Dialysis
|
3.95 (2.19–7.12)
|
<0.001
|
|
Diabetes Mellitus
|
1.60 (1.17–2.21)
|
0.004
|
|
Peripheral arterial disease
|
1.39 (0.91–2.14)
|
0.12
|
|
Pre-Operative CCS
|
1.01 (0.87–1.18)
|
0.85
|
|
Pre-Operative NYHA
|
0.86 (0.71–1.06)
|
0.15
|
|
Pre-Operative Leukocyte
|
1.05 (0.99–1.11)
|
0.11
|
|
Pre-Operative Neutrophils
|
1.08 (1.02–1.15)
|
0.01
|
|
Pre-Operative Lymphocytes
|
0.69 (0.55–0.88)
|
0.003
|
|
Pre-Operative Monocytes
|
1.46 (0.91–2.36)
|
0.11
|
|
Pre-Operative Creatinine
|
1.20 (1.09–1.31)
|
<0.001
|
|
Pre-Operative Glucose
|
1.00 (1.00–1.01)
|
<0.001
|
|
Pre-Operative NLR
|
1.09 (1.06–1.13)
|
<0.001
|
|
Operative and postoperative data
| | |
|
Internal mammary artery used
|
0.35 (0.21–0.57)
|
<0.001
|
|
Number of conduits used for bypass
|
0.96 (0.82–1.13)
|
0.64
|
|
Renal failure on dialysis
|
6.80 (3.91–11.80)
|
<0.001
|
|
Cardiopulmonary bypass
|
1.76 (1.11–2.79)
|
0.01
|
|
New onset atrial fibrillation
|
2.03 (1.41–2.91)
|
<0.001
|
|
Septicemia
|
6.95 (3.54–13.65)
|
<0.001
|
